Physician profile
Jeffrey D Day
NPI 1780652370
$2,229.24
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $268 · 2021: $342 · 2022: $576 · 2023: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $830 · Food and Beverage: $44.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $830.41 |
| Food and Beverage | $44.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,355.95 | 2021-2023 | Opalescence |
| Align Technology, INC. | $228.14 | 2019-2022 | |
| Dentsply Sirona INC | $217.21 | 2020-2023 | Cerec |
| Biohorizons Implant Systems INC. | $140.06 | 2019-2023 | Biohorizons |
| Henry Schein, INC. | $103.54 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $66.19 | 2019 | |
| Straumann USA LLC | $43.17 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $31.02 | 2021-2022 | |
| Purelife, LLC | $20.00 | 2019 | |
| 3m Company | $14.08 | 2021 | |
| Voco America INC. | $9.88 | 2023 | Admira Protect, Ionoseal, Profluorid L |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.